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Tapasin is a glycoprotein critical for loading major
histocompatibility complex (MHC) class I molecules
with high-affinity peptides. It functions within the
multimeric peptide-loading complex (PLC) as a
disulfide-linked, stable heterodimer with the thiol
oxidoreductase ERp57, and this covalent interaction
is required to support optimal PLC activity. Here, we
present the 2.6 A˚ resolution structure of the tapasin-
ERp57 core of the PLC. The structure revealed that
tapasin interacts with both ERp57 catalytic domains,
accounting for the stability of the heterodimer, and
provided an example of a protein disulfide isomerase
family member interacting with substrate. Mutational
analysis identified a conserved surface on tapasin
that interacted with MHC class I molecules and was
critical for peptide loading and editing functions of
the tapasin-ERp57 heterodimer. By combining the
tapasin-ERp57 structure with those of other defined
PLC components, we present a molecular model
that illuminates the processes involved in MHC class
I peptide loading.
INTRODUCTION
Major histocompatibility complex (MHC) class I molecules
present peptide antigens recognized by CD8+ T cells and are
critical for immune responses to viruses and tumors. The reper-
toire of peptides bound is extremely diverse, and the preferential
loading of high-affinity peptides contributes to the most effective
stimulation of a T cell response.MHCclass Imolecules consist of
heavy-chain-b2-microglobulin (HC-b2m) dimers that fold and
assemble with eight to ten residue peptides in the endoplasmic
reticulum (ER) (Cresswell et al., 2005). Final assembly and
peptide binding take place within the peptide-loading complex
(PLC), where HC-b2m heterodimers undergo ‘‘peptide editing’’
to promote preferential loading and cell-surface presentation
of high-affinity peptides (Elliott and Williams, 2005). In this final
quality-control step, tapasin, a specific chaperone critical for
the stabilization and loading of empty MHC class I molecules,cooperates with other more general, ER-resident chaperones.
Tapasin is linked by a uniquely stable bond to an active-site
cysteine residue of the thiol oxidoreductase ERp57 (Dick et al.,
2002; Peaper et al., 2005), and the tapasin-ERp57 heterodimer
recruits MHC class I molecules as well as the lectin-like chap-
erone calreticulin to the PLC (Wearsch and Cresswell, 2007).
Tapasin also binds to the transporter associated with antigen
presentation (TAP) (Ortmann et al., 1997), localizing empty MHC
class I molecules near the source of antigenic peptides.
The discovery that tapasin forms an unusually stable hetero-
dimer with ERp57 redirected our understanding of its structure
and function (Dick et al., 2002; Peaper et al., 2005). ERp57 is
a member of the protein disulfide isomerase (PDI) family of thiol
oxidoreductases and normally facilitates disulfide-bond forma-
tion during glycoprotein folding in conjunction with calreticulin
and calnexin (Helenius and Aebi, 2004). It consists of four
thioredoxin-like domains, a, b, b0, and a0. The a and a0 domains
have Cys-Gly-His-Cys active-site motifs (C57-G58-H59-C60 and
C406-G407-H408-C409) and are catalytically active (Ellgaard and
Ruddock, 2005). A transient disulfide bond forms between the
N-terminal cysteine in the catalytic motif and a substrate, which
is subsequently resolved when the C-terminal cysteine attacks
the N-terminal cysteine to release the substrate, a step called
the ‘‘escape pathway’’ (Walker and Gilbert, 1997). Within the
PLC, Cys57, the N-terminal residue in the catalytic motif of the
ERp57 a domain, forms a disulfide bond with Cys95 of tapasin
(Dick et al., 2002). Unlike other ERp57 substrates, however, this
disulfide bond is preserved by noncovalent interactions with
tapasin, generating the stable heterodimer (Peaper et al., 2005).
The formation of the tapasin-ERp57 ‘‘conjugate’’ is required for
maintaining the structural stability of thePLCaswell as facilitating
optimal peptide loading in human cells (Dick et al., 2002; Peaper
and Cresswell, 2008). Furthermore, the tapasin-ERp57 hetero-
dimer, but not monomeric tapasin, supports PLC assembly, the
stabilization of emptyMHCclass Imolecules, andpeptide editing
in vitro (Wearsch and Cresswell, 2007).
Here, as a framework for understanding PLC function, we
present the 2.6 A˚ structure of its tapasin-ERp57 core. The struc-
ture offers a view of a PDI family member interacting with its
protein substrate while also explaining the molecular basis for
the unusually stable association of ERp57 and tapasin. Further,
we identify a conserved surface on tapasin that mediates the
recruitment and peptide loading of MHC class I molecules, andImmunity 30, 21–32, January 16, 2009 ª2009 Elsevier Inc. 21
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class I peptide-binding groove in an open, peptide-receptive
conformation that facilitates peptide binding. The tapasin-
ERp57 structure and MHC class I binding interface established
here, combined with known structures of PLC components
and previously established points of contact between them,
have allowed us to develop a rational model of the specialized
ER quality-control complex that mediates peptide loading by
MHC class I molecules.
RESULTS
Structure Overview
The heterodimer of the lumenal region of tapasin and ERp57 was
expressed in Sf21 insect cells and purified as described previ-
ously (Wearsch and Cresswell, 2007). To obtain the high yields
required for crystallographic studies, we coexpressed tapasin
with ERp57 bearing the C60A trapping mutation. The mutant
conjugates have identical in vitro activity to those containing
wild-type ERp57 and improved stability during purification
(Wearsch and Cresswell, 2007). We obtained two crystal forms
of the purified conjugate. The structure was initially solved to
3.3 A˚ resolution by single-wavelength anomalous scattering
(SAD) with selenomethionine (SeMet)-substituted crystals con-
taining one tapasin-ERp57 complex in each asymmetric unit.
The resolution was extended to 2.6 A˚ with data from a second
crystal form with two complexes in each asymmetric unit. In the
final 2.6 A˚ model, one copy of ERp57 comprises residues
25–493, excluding the signal sequence (residues 1–24) and the
C terminus (residues 494–501); the second copy consists of resi-
dues 25–41 and 46–490. Residues 1–381 of tapasin aremodeled,
excluding poorly ordered regions (residues 12–19, 28–33, and
171–176 in one copy of tapasin and 12–17, 29–32, 173–176,
and 316–320 in the second copy). The final model also contains
112 water molecules and the N-acetyl glucosamine groups of
the glycan linked to Asn233 in tapasin. Data and refinement
statistics are listed in Table 1.
Tapasin forms an L-shaped structure, whereas the four
domains of ERp57 are arranged in a twisted U. The a and a0
domains of ERp57 are at the ends of the U, with each contacting
the N-terminal domain of tapasin (Figure 1). The heterodimer
measures140 A˚ in its longest direction and80 A˚ in thewidest.
Between the bb0 domains of ERp57 and theN-terminal domain of
tapasin, there is an elliptical cavity measuring 10 by 30 A˚ in
diameter. Tapasin consists of two domains, comprising residues
1–269 and 270–381, respectively. The N-terminal domain is
a fusion of a seven-stranded b barrel (residues 1–147, b strands
S1–S7) and an immunoglobin (Ig)-like fold (residues 150–269,
b strands S8–S14) (Figures 1A and 1B). The connectivity within
the b barrel is unusual with respect to other structures in the
Protein Data Bank, as determined by DALI (Holm and Sander,
1996). The N-terminal domain can also be described as
a three-tiered b sheet sandwich, in which two smaller antiparallel
b sheets (S1-S2-S3 and S10-S9-S13-S14) are stacked on oppo-
site sides of an extended central sheet (S4-S5-S6-S7-S8-S12-
S11). The C-terminal domain of tapasin also forms an Ig-like
fold. The N and C termini are both stabilized by disulfide bonds,
between Cys7 and Cys71 and between Cys295 and Cys362,
respectively, consistent with previous reports (Dick et al., 2002;22 Immunity 30, 21–32, January 16, 2009 ª2009 Elsevier Inc.Turnquist et al., 2004). The relative orientation of the N- and
C-terminal domains is similar in two of the three independent
copies of tapasin but differs by 8 in the third (Figures S1A
and S1B available online).
The arrangement of the four thioredoxin-like domains of
ERp57 resembles that observed for yeast PDI (PDB ID 2B5E;
Tian et al., 2006), which is similar in sequence (29% identity over-
all and 48% and 43% identity in a and a0, respectively). Although
the relative orientations of all four domains are similar in two of
the three independent copies of the tapasin-ERp57 conjugate
in the crystal structures, they differ in the third. Here, a and b,
b and b0, and b0 and a0 are reoriented by 7, 10, and 15,
respectively, suggesting flexibility between domains (Figure S1).
A comparison with the crystal structure of the bb0 fragment alone
(PDB ID 2H8L; Kozlov et al., 2006) shows that the range of hinge
motion is up to 14 between the b and b0 domains. The relative
orientation and spacing of a and a0 are fixed by their interaction
with tapasin; however, even in the absence of tapasin, ERp57
adopts a U shape in solution (Kozlov et al., 2006). Thus, the
flexibility between domains in both tapasin and ERp57 appears
to be limited.
Table 1. Data Collection and Refinement Statistics
Data Collection
Space Group
P21
P212121 (seMet-
substituted proteins)
Wavelength 0.9795 0.9792
Cell parameters a = 74.1, b = 72.3,
c = 200.2 A˚, b = 94.6
a = 72.6, b = 74.8,
c = 202.4 A˚
Resolution (A˚) 2.6 (2.692.60) 3.3 (3.423.30)
Rsym (%) 7.1 (20.7) 9.6 (35.0)
I/sI 19.4 (6.5) 29.8 (6.3)
Completeness (%) 98.1 (91.4) 99.5 (100.0)
Redundancy 3.7 (3.6) 22.6 (22.0)
Refinement
Resolution (A˚) 20.02.6 20.03.3
Number of reflections 63,580 31,455
Rwork/Rfree (%) 24.46/28.17a 26.75/33.88
Number of atoms 13,055 6,504
Protein/carbohydrate 12,915 6,504
Water 112 -
Average B factor (A˚2) 63.0b 92.3
Rmsds
Bond lengths (A˚) 0.0073 0.0101
Bond angles () 1.44 1.60
Ramachandran plot
Most favored (%) 88.2 68.6
Allowed (%) 11.2 29.5
Generously allowed (%) 0.6 1.9
Disallowed (%) 0.1 0.0
Numbers in parentheses refer to data in the highest resolution bin.
a Two-fold noncrystallographic symmetry (NCS) restraints were used
during positional refinement.
b The average B factors for ERp57 are 54.5 and 78.5 A˚2, and for tapasin
molecules they are 56.9 and 58.5 A˚2.
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Figure 1. The Structure of the Tapasin-ERp57 Heterodimer
(A) Ribbon diagramwith ERp57 in white. The N-terminal domain of tapasin is a fusion of a b barrel (green) and an Ig-like domain (yellow); the C terminus is an Ig-like
domain (blue).
(B) Sequence alignment for tapasin. Residues in humans, mice, chickens, and zebrafish that are identical or similar are red or orange, respectively. Residues
within 4.5 A˚ of an ERp57 atom are boxed in black. Secondary-structure elements are labeled. Mutations that interfere with MHC class I interaction and function
are indicated (TN3–TN6).Immunity 30, 21–32, January 16, 2009 ª2009 Elsevier Inc. 23
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The interactions between tapasin and the a and a0 domains of
ERp57 are similar in all three crystallographically independent
copies of the complex, indicating that the interfaces are not crys-
tallization artifacts. Interestingly, the a and a0 domains of ERp57
use equivalent surfaces to interact with tapasin, with the catalytic
motifs in both domains buried in the interface (Figures 2A–2C,
Table S1). The a domain of ERp57 interacts with a long loop in
the b barrel portion of the tapasin N-terminal domain. The loop
spans residues 77–102 (between S4 and S5), and, consistent
with previous findings (Dick et al., 2002), there is a covalent
bond betweenCys95 in this loop andCys57 in the catalyticmotif.
The a0 domain of ERp57 forms an interface with residues in S10
and S11 in the Ig-like portion of the tapasin N terminus. Cys406
and Cys409 in the a0 catalytic motif form an intramolecular disul-
fide bond, and neither is positioned so as to bond with a cysteine
residue in tapasin.
Comparison of the domain a catalytic motifs in ERp57 and
yeast PDI showed that tapasin binding does not markedly distort
the geometry of the catalytic motif or sterically hinder the
C-terminal Cys60 from attacking the Cys57ERp57-Cys95tapasin
disulfide bond (Figure 2D), required for the escape pathway.
Thus, the stable association of ERp57 with tapasin does not
appear to involve a direct effect on the mechanism of catalysis;
rather, the interaction is stabilized by cumulative protein-protein
interactions. Because both catalytic domains interact with tapa-
sin, the interface is approximately doubled relative to that for
a typical substrate, which would be expected to interact with
only a single domain. The surface area occluded in the ERp57-
tapasin interface, 1580 A˚2, falls in the range most frequently
observed for protein-protein interactions, 1400–3000 A˚2 (Reich-
mann et al., 2007). This larger interaction surface probably
contributes to the lectin-independent recruitment of tapasin by
ERp57 and the unusually stable association of the two proteins
(Cresswell et al., 2005). Consistent with this, perturbing the inter-
face between tapasin and the ERp57 a0 domain by mutation of
ERp57 (C406A, C409A) markedly diminishes the efficiency of
complex formation (Dick et al., 2002).
In vivo, tapasin forms a mixed disulfide bond with ERp57, but
not with the closely related ER-resident enzymes ERp72 and PDI
(D.R.P., unpublished data). Both ERp72 and PDI share high
sequence identity with ERp57 in the interacting a and a0 domains
(45%–57%), and most of the tapasin-contact residues are abso-
lutely conserved in ERp57, PDI, and ERp72 (Figure 2C). Thus, the
sequences of the catalytic domains may not be the sole determi-
nant for recognition. Another may be their relative orientation and
spacing, dictated by their binding sites on tapasin. In the tapasin-
ERp57 conjugate, the distance between the two domains,
measured by the distance between the Ca atoms in Cys57 and
Cys406, measures 34 A˚. The distance between the equivalentatoms in yeast PDI, the only other PDI family member for which
the complete structure is known (Tian et al., 2006), is shorter at
26.5 A˚. Although flexibility at the domain interfaces may allow
each protein to sample a range of distances or orientations,
the range may vary for different members of the PDI family.
Domains a and a0 in ERp72 and PDI may not be able to accom-
modate the 34 A˚ distance while maintaining the orientation
required for tapasin interaction, thereby making them unable to
trap tapasin as ERp57 does.
A Conserved Surface in Tapasin Important
for PLC Function
Within the PLC, the empty MHC class I heterodimer is thought to
be stabilized and loadedwith peptides via direct interactionswith
tapasin (Elliott, 1997;Wright et al., 2004;ChenandBouvier, 2007).
Mutants of the MHC class I heavy chain that affect PLC binding
have been well established (Carreno et al., 1995; Peace-Brewer
et al., 1996; Harris et al., 1998; Lewis and Elliott, 1998; Yu et al.,
1999), but the functionally important interface on tapasin has
yet to be defined. To map potential sites of interaction with the
MHC class I molecule, we compared the sequences of tapasin
from different species and identified a prominent conserved
patch on the surface of the N-terminal domain (Figures 3A and
3B). Residues in this patch and other surfaces of tapasin were
mutated (Table 2 and Figure 3C) and tested for their effect on
PLC function.
Recombinant tapasin-ERp57 conjugate interacts with
peptide-free MHC class I HC-b2m heterodimers present in
extracts of tapasin-negative cells and facilitates MHC class I
binding of high-affinity peptides in a cell-free system (Wearsch
and Cresswell, 2007). Our initial screening of the mutants used
this same approach to identify the region of tapasin that interacts
with MHC class I molecules. We coexpressed eight different
tapasin mutants (Table 2 and Figure 3C) with C60A ERp57 in
Sf21 insect cells and purified the recombinant proteins. All
tapasin mutants were stably expressed and efficiently formed
the conjugate with ERp57 (Figure S2). To analyze for the MHC
class I interaction, we incubated extracts from tapasin-negative
.220.B*0801 cells, which are enriched for empty MHC class I
heterodimers, with purified conjugates immobilized on beads
with the tapasin-specific monoclonal antibody (mAb) PaSta1.
Tapasin-associated MHC class I molecules were identified by
pull-down and immunoblotting. As shown in Figure 4A, we
observed a normal interaction between MHC class I heavy chain
and the recombinant conjugates containing wild-type tapasin,
two of the mutants in the amino terminal regions (TN1 and
TN2) that are most distant to the conserved patch, and the single
mutant in the carboxy terminal region (TC1). The five other tapa-
sinmutants had variable effects (Figure 4A). The TN6mutation, in
which residues central to the conserved patch were altered,Figure 2. Interactions between Tapasin and ERp57
(A) Tapasin residues within 4.5 A˚ of an ERp57 atom are labeled.
(B) ERp57 has been pulled away from tapasin and rotated 180 about a vertical axis for exposing the tapasin-interaction surface. Residues at the tapasin interface
are labeled. Contacts between tapasin and ERp57 are listed in Table S1.
(C) Sequence alignment of ERp57 domains a and a0 and equivalent domains of other ER-resident PDIs. Residues in ERp57 within 4.5 A˚ of a tapasin atom are
boxed green (domain a) or yellow (domain a0). Catalytic motifs are red. Secondary structure is indicated.
(D) Domains a from yeast PDI (PDBID 2B5E) and ERp57were superimposed. The catalytic motif in domain a of ERp57 (white) is not distorted when tapasin (green)
is bound as compared with the equivalent motif in yeast PDI (red). Disulfide bonds are yellow.Immunity 30, 21–32, January 16, 2009 ª2009 Elsevier Inc. 25
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Figure 3. A Conserved Surface in Tapasin Is Important for PLC Assembly and Function
(A) Space-filling representation of tapasin-ERp57with surface residues colored red and orange as in Figure 1B. For underlined residues, the side chain forms part
of the protein core. The complex is oriented as in Figure 1A.
(B) The complex has been rotated 180 around a vertical axis.
(C) Residues that were mutated are colored (Table 2). Mutations that affect PLC assembly or function are colored in shades of red. Other mutations are blue
or green.completely abrogated MHC class I binding. Only trace amounts
of MHC class I heavy chains were found to interact with mutants
TN3, TN4, TN5, and TN7, which are located in or around the
conserved patch.
The relative abilities of the mutants to bind to MHC class I
molecules closely matched their relative capacities for mediating
peptide loading. Using the assay previously described (Wearsch
and Cresswell, 2007), we measured the ability of the recombi-
nant conjugates to promote the binding of the human leukocyte
antigen (HLA)-B8-specific peptide NP(380–387L) to empty MHC
class I molecules present in .220.B*0801 extracts (Figure 4B).
Again, the most dramatic effect was observed for TN6, which re-
tained less than 10% of the activity observed for the wild-type
tapasin-ERp57 conjugate (Table 2). For the TN3, TN4, TN5,
and TN7 mutants that displayed impaired MHC class I binding,
the ability to catalyze peptide loading was reduced to between
42% and 68% of wild-type levels, whereas TN1, TN2, and TC1
were normal.
As a further test of functionality, we used retroviral transduc-
tion to introduce the TN6 mutant into the tapasin-negative
.220.B*4402 cell line, along with TN1, as a control, and C95A
tapasin (Dick et al., 2002; Peaper and Cresswell, 2008), which
does not form the conjugate or support optimal PLC function.
Cell-surface expression of HLA-B*4402 is highly tapasin depen-
dent, consistent with the role of tapasin in facilitating peptide
loading (Peh et al., 1998). FACS analysis of the transduced cells
showed that the TN6 mutant failed to restore surface expression
of HLA-B*4402 (Figure 4C), even though its level of intracellular
expression was similar to that of wild-type tapasin (data not26 Immunity 30, 21–32, January 16, 2009 ª2009 Elsevier Inc.shown). The TN1 mutant and wild-type tapasin restored surface
expression, whereas the C95A tapasin mutant, as shown previ-
ously (Dick et al., 2002), only partially restored class I expression.
This level of restoration, 60% of wild-type, may be a result of a
low but substantial interaction between free tapasin and MHC
class I not reflected in our in vitro measurements of activity,
combined with the known stabilization of TAP amounts by
tapasin association (Bangia et al., 1999; Garbi et al., 2003), which
increases the supply of peptides in the ER. Nevertheless, consis-
tent with the data obtained with recombinant tapasin-ERp57
conjugates (Figure 4A), no MHC class I heavy chains were
detectably associated by coimmunoprecipitation with the PLC
in TN6-expressing cells, although this mutant associated nor-
mally with TAP (Figure 4D). Thus, the conserved surface in the
N-terminal domain of tapasin probably represents the dominant
site of interaction with MHC class I molecules.
Further evidence that the region of tapasin defined by muta-
tional analysis is responsible for the MHC class I HC interaction
was obtained with a second tapasin-specific mAb, PaSta2. This
antibody recognizes free tapasin-ERp57 conjugates just as well
as PaSta1 (Figure 4F and data not shown), but it does not immu-
noprecipitate MHC class I-associated tapasin. This behavior
was demonstrated when purified wild-type tapasin-ERp57
conjugates were incubated with extracts from .220.B*0801 cells
and then subjected to immunoprecipitation with either PaSta1 or
PaSta2 (Figure 4E). Dose-dependent reconstitution of the MHC
class I-tapasin interaction was confirmed by immunoprecipita-
tion with PaSta1, but these complexes could not be isolated
with PaSta2. Thus, the tapasin-MHC class I interaction appears
Immunity
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to localize the epitope, we screened the recombinant conjugates
containing the tapasin mutants (Table 2) for binding to PaSta2.
Immunoprecipitation for all of the mutants with PaSta1 and
PaSta2 was equal except for the TN7 mutant (data not shown
and Figure 4F), which is adjacent to the highly conserved tapasin
surface (Figure 3C) and is partially defective for MHC class I
association and peptide loading (Figures 4A and 4B). The triple
mutation generated in TN7 is H190S, L191A, K193E. Notably,
mouse tapasin, which has an arginine in place of leucine at
residue 191 (Figure 1B), was not recognized by PaSta2 (data
not shown). Thus, the PaSta2 epitope, which is blocked by the
MHC class I interaction, is proximal to the highly conserved
surface of tapasin that interacts with MHC class I molecules.
Modeling the PLC
Two long helices, a1 and a2, form the walls of the MHC class I
peptide-binding groove. Molecular-dynamics simulations as
well as the crystal structure of a peptide-free MHC class I-like
molecule (Olson et al., 2005; Zacharias and Springer, 2004)
support the proposal that in the absence of peptide, the binding
grooveadopts an ‘‘open’’ conformation characterizedbymobility
in the N-terminal segment of helix a2, a2-1 (Elliott, 1997). Tapasin
is thought to stabilize a peptide-receptive, open conformation of
MHCclass I, andmutations on the same side as a2-1 affect tapa-
sin binding (Figures 5A and 5B) (Carreno et al., 1995; Peace-
Brewer et al., 1996; Lewis and Elliott, 1998; Yu et al., 1999). We
suggest that the conserved, functionally important surface of
tapasin that we have identified serves to stabilize helix a2-1 while
the binding groove maintains an open conformation. Both
tapasin and MHC class I are tethered to the ER membrane by
C-terminal transmembrane segments, and, given this restraint,
the two molecules can be juxtaposed so that the conserved
surface in tapasin is accessible to a2-1 (Figures 5A and 5B).
The shallow trough within which the conserved residues are
located (Figures 3A and 3C) could easily accommodate and
stabilize ashort helix suchasa2-1.Within thePLC, theMHCclass
I molecule would then remain primarily in an open conformation
until peptide binds with high affinity, locking it into the ‘‘closed’’
Table 2. In Vitro Activity of Mutant Tapasin-ERp57 Conjugates
Name Mutation
Color in
Figure 3C
MHC Class I
Association
Peptide
Loading (%)a
WT - - ++++ 100
TN1 E6K, W8A cyan ++++ 108 ± 4
TN2 R37E, D39K blue ++++ 114 ± 8
TN3 E72K medium pink + 58 ± 3
TN4 E11K, D12R light pink +/ 41 ± 5
TN5 L250K orange +/ 32 ± 4
TN6 E185K, R187E,
Q189S, Q261S
pink - 8 ± 1
TN7 H190S, L191A,
K193E
light orange +/ 53 ± 2
TC1 S303W, E307K,
E309K
green ++++ 99 ± 13
aPercentage of WT activity ± standard error of the mean (SEM), repre-
senting the average of two experiments.conformation observed in peptide-bound structures. This
weakens the interaction with tapasin, releasing the class I mole-
cule from the PLC and allowing it to move to the plasma
membrane for recognition by CD8+ T cells.
Atomic-resolution structures of the peptide-bound form of
MHC class I (we used PDB ID 1DUY [Khan et al., 2000] for HLA-
A*0201) and of the calreticulin homolog calnexin are available
(PDB ID 2JHN [Schrag et al., 2001]), as is a vast body of biochem-
istry regarding the interactions of the MHC class I molecule with
tapasin and calreticulin and of calreticulin and calnexin with
ERp57 (Wright et al., 2004). Combining these data with the
tapasin-ERp57 structure and the MHC class I interaction site
identified here allowed us to generate a rationalmodel of the sub-
complex of the PLC containing the lumenal components (Figures
5C and 5D). Class I heavy-chain residues known to interact with
tapasin (Carreno et al., 1995; Peace-Brewer et al., 1996; Lewis
andElliott, 1998; Yu et al., 1999) aremodeled at the tapasin-class
I interface, and helix a2-1 is near the conserved, functionally
important surface of tapasin we have identified (Figures 5A and
5B). For calreticulin, we have substituted the calnexin structure,
but with an appropriately shortened proline-rich P domain. The
lectin-binding site of calreticulin (Thomson and Williams, 2005)
is placed proximal to the N-linked glycan at Asn86 of the MHC
class I heavy chain, which, in the monoglucosylated form, is
known to interact with calreticulin (Harris et al., 1998; Wearsch
et al., 2004). The P domain is flexible (Ellgaard et al., 2002), and
it was incorporated into the model so that its tip is adjacent to
the basic surface of the ERp57 b0 domain known to interact
with this region of calnexin and calreticulin (Kozlov et al., 2006;
Russell et al., 2004).
Additional evidence in support of the model structure indi-
cated in Figure 5 is provided by an MHC class I mAb epitope
that is the only one known to be expressed and readily acces-
sible on MHC class I molecules present in the PLC. The 64-3-7
epitope has been used for defining the open conformation of
class I putatively present in the PLC. It is present in H2-Ld mole-
cules, can be transferred to other MHC alleles, and corresponds
to residues 46–52 in the MHC class I heavy chain (Hansen et al.,
2005). This sequence, which lies toward the N-terminal end of
the a1 helix, would be easily available to an antibody in the struc-
ture proposed (Figure 5C). Tapasin residue 191, which is part of
the PaSta2 epitope obscured byMHC class I binding, is buried in
the MHC class I-tapasin interface.
DISCUSSION
Determination of the tapasin-ERp57 structure allows us to
address several outstanding questions regarding the architec-
ture and functionof thePLC. Inparticular,weevaluate twocentral
issues. First, what is the mechanism and function of covalent
sequestration of ERp57 by tapasin? Second, how do tapasin
and the other PLC components interact with empty MHC class
I molecules to facilitate their stabilization and loading with
high-affinity peptides?
We previously postulated that the disulfide bond formed
between tapasin and ERp57 is preserved as a consequence of
noncovalent interactions (Peaper et al., 2005). The structure
provides no evidence that the escape pathway is inhibited by
perturbation of the a domain active site. Instead, it appears thatImmunity 30, 21–32, January 16, 2009 ª2009 Elsevier Inc. 27
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(A) In vitro assay for the association of MHC class I molecules with wild-type (WT) and mutant tapasin-ERp57 conjugates. Digitonin extracts from .220.B*0801
cells were incubatedwith 250 nMof the indicated recombinant conjugates immobilized on beads. Samples were washed, analyzed bv SDS-PAGE, and subjected
to immunoblotting (IB) for the MHC class I heavy chain. Data are representative of at least three independent experiments.
(B) In vitro assay comparing the ability of the recombinant tapasin-ERp57 conjugates to facilitate MHC class I peptide loading. Extracts were prepared from
.220.B*0801 cells and incubated with 250 nM recombinant conjugate and [125I]-NP(380-387L). Immunoprecipitation of MHC class I molecules was then per-
formed with the W6/32 Ab, and peptide loading was measured by gamma counting. Activities were normalized to that of the wild-type tapasin-ERp57 conjugate.
Data are an average of two independent experiments ± the SEM.
(C) The ability of the indicated tapasin constructs to restore HLA-B*4402 expression in tapasin-deficient cells was analyzed by FACS. .220.B*4402 cells trans-
duced with the indicated constructs were stained with anti-HLA-A,B,C, and cell-surface expression was quantitated for EGFP+ cells. Data are representative of
two independent experiments.
(D) PLC composition in transduced .220.B*4402 cells. Immunoprecipitations were performed from digitonin extract, analyzed by nonreducing SDS-PAGE, and
transferred to membranes for immunoblotting with Abs to TAP and MHC class I heavy chain.
(E) The PaSta2 mAb does not bind to MHC class I-associated tapasin. Extracts of .220.B*0801 cells were supplemented with the indicated concentrations of
purified tapasin-ERp57 conjugate and subjected to immunoprecipitation with either PaSta1 or PaSta2 and immunoblotting for the MHC class I heavy chain.
(F) The TN7 mutation of tapasin eliminates recognition by PaSta2. Extracts were either prepared from uninfected Sf21 cells (-) or those infected with baculovirus
for the indicated tapasin-ERp57 conjugates were immunoprecipitated with either PaSta1- or PaSta2-coupled beads and analyzed by nonreducing SDS-PAGE.
Proteins were visualized by staining with Coomassie blue.the heterodimer is stabilized by the association of tapasin with
both of the active sites of ERp57. This finding has several implica-
tions. It suggests that tapasin has evolved and acquired these
noncovalent interactions as the primary means for stabilizing
what would otherwise be a transient mixed disulfide between
ERp57 and substrate. It is also consistent with the evidence that
the stable, covalent associationwith ERp57 has a direct effect on
the activity of tapasin (Wearsch and Cresswell, 2007) and with28 Immunity 30, 21–32, January 16, 2009 ª2009 Elsevier Inc.speculation that it might affect tapasin conformation. Lastly, the
association of tapasin with both active sites of ERp57 has strong
implications regarding the role of ERp57 in the PLC.
ERp57 functions in the early oxidative folding of theMHCclass
I heavy chain (Zhang et al., 2006), and some studies have also
suggested a role for its enzymatic activity within the PLC, i.e.,
in reduction and oxidation of the disulfide bond at the base of
the MHC class I peptide-binding groove (Dick et al., 2002;
Immunity
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Figure 5. In SilicoModel of the Lumenal Sub-
complex of the PLC
The model is based on known structures of PLC
components, or their homologs, and protein-
protein interaction data. Structures of tapasin
(gray) and MHC class I (green) are juxtaposed in
(A) and (B), so that residues important for their
interaction are at or near the protein interface.
(A) Mutations in tapasin (space-filling model) that
affect PLC assembly are colored as in Figure 3
and Table 2. The heavy chain is dark green, and
b2m is lighter. Helices a1, a2-1, and a2-2 that define
the MHC class I peptide-binding groove are indi-
cated, and a red line marks the groove.
(B) The MHC class I molecule (space-filling model)
is juxtaposed with tapasin. Residues in the heavy
chain that are important for interactions with
tapasin (Carreno et al., 1995; Peace-Brewer et al.,
1996; Lewis and Elliott, 1998; Yu et al., 1999) are
highlighted yellow.
(C) Side view of the assembled subcomplex, with
tapasin, ERp57, MHC class I, and calreticulin.
Residues in the ERp57 b0 domain that interact
with the calreticulin P loop are blue (Kozlov et al.,
2006; Russell et al., 2004). The 64-3-7 epitope of
MHC class I heavy chains (H2-Ld) that is accessible
in the PLC is white.
(D) Top view of the assembled subcomplex. The
MHC class I molecule is shown with a semitrans-
parent surface. The site of glycosylation at Asn86
in the heavy chain is indicated. This glycan is bound
in the calreticulin glucose-binding pocket. Calreti-
culin residues important for glucose binding are
labeled blue (Thomson and Williams, 2005).Lindquist et al., 2001; Santos et al., 2007). In the crystal structure,
however, both ERp57 active sites are engaged in contacts with
tapasin and are inaccessible to the MHC class I molecule.
Althoughwe cannot exclude that ERp57may assume an alterna-
tive conformation within the PLC, the structures described
here suggest that tapasin-associated ERp57 does not exhibit
redox activity. In further support of this conclusion, we recently
found by mutational analysis that the cysteines in the ERp57
a0 catalytic motif are not required for efficient MHC class I
peptide loading (Peaper and Cresswell, 2008). Although the
structure is not inconsistent with the conclusion by Dick and
coworkers (Kienast et al., 2007) that tapasin inhibits the redox
activity of ERp57 to prevent reduction of class I heavy chains,
we favor an alternate explanation for the role of tapasin-ERp57
conjugation and a positive role for ERp57 in peptide loading.
Other studies (Garbi et al., 2006; Peaper and Cresswell, 2008;
Wearsch and Cresswell, 2007) better support a model in which
tapasin has adapted the quality-control machinery by covalently
sequestering ERp57 in order to enhance the recruitment and
stability within the PLC of empty MHC class I molecules associ-
ated with calreticulin, which interacts independently with the
class I glycan and the bb0 domains of ERp57 (Helenius and
Aebi, 2004).Speculation regarding the mechanism by which tapasin
regulates peptide binding to MHC class I molecules has often
centered on comparisons with that of HLA-DM (DM), which
performs a similar function for MHC class II (Busch et al., 2005;
Sadegh-Nasseri et al., 2008). Although superficially the
processes are similar, tapasin function is clearly more complex
in that it operates in cooperation with a number of other compo-
nents, including its heterodimeric partner, ERp57. The structure
of the tapasin-ERp57 heterodimer revealed here increases our
appreciation for the differences between the two; DM is a struc-
tural homolog of class II molecules themselves (Fremont et al.,
1998; Mosyak et al., 1998), whereas tapasin lacks any resem-
blance to DM or MHC molecules except that all are members
of the immunoglobulin superfamily.
Themodelwehave generated of the luminal subcomplex of the
PLC offers new insights into the events that occur during MHC
class I peptide loading. Association of the a2-1 helix of the MHC
class I molecule with the conserved surface patch identified in
tapasin is likely to stabilize the binding groove in a peptide-recep-
tive form. Peptide binding is proposed to reduce the affinity of the
tapasin-class I interaction, and prolonged association with high-
affinity peptide would result in release of the completely assem-
bled MHC class I molecule from the PLC. The conformation ofImmunity 30, 21–32, January 16, 2009 ª2009 Elsevier Inc. 29
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possible, but in all likelihood it forms an arm that encloses the
empty MHC class I peptide-binding groove. This could protect
the incompletely assembled MHC class I molecule from reduc-
tion by free, non-PLC-associated ERp57 or other thiol oxidore-
ductases in the ER, such as PDI. It may also protect the still
improperly folded empty peptide-binding groove from recogni-
tion by other ER chaperones that might target the peptide-free
MHC class I molecule for degradation. Furthermore, data from
Shastri and coworkers (Kanaseki et al., 2006) have argued that
binding of N-terminally extended peptides to MHC class I mole-
cules followed by trimming by the enzyme ERAAP or ERAP-1 is
likely to occur during peptide loading. In the MHC class I orienta-
tion in the model, the N-terminally extended peptides transiently
associated with MHC class I molecules within the PLC would be
accessible to ERAAPor ERAP-1. This suggests that such peptide
trimming need not be restricted toMHCclass Imolecules that are
freely diffusing in the ER membrane.
More than a decade has passed since the discovery of tapasin
and the PLC, and yet much work remains before we fully under-
stand the mechanisms by which they facilitate peptide loading
and editing. A major obstacle to designing experiments to probe
this mechanism has been the lack of structural information
regarding the PLC and, in particular, the MHC class I-specific
chaperone tapasin. Thus, the structure of the tapasin-ERp57
heterodimer and the molecular model for the lumenal subcom-
plex of the PLC that we present here not only represent a major
step toward better understanding the architecture and function
of the PLC, but, equally importantly, will serve as a powerful
springboard for further mechanistic probing.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The lumenal domain of human tapasin with a 6x His tag was cloned into the
pFastBac Dual vector (Invitrogen) along with full-length human ERp57 bearing
the C60A mutation (Wearsch and Cresswell, 2007). The native proteins were
coexpressed in Sf21 insect cells, and the resulting ‘‘C60A conjugate’’ was
purified as described (Wearsch and Cresswell, 2007). After the final chroma-
tography step, buffer was exchanged and protein was concentrated to
10 mg/ml in 150 mM NaCl, 10 mM Tris (pH 7.4), 5% glycerol.
SeMet-substituted proteins were expressed in Hi-5 insect cells and purified
by modified protocols. Insect cells were initially grown in EX-CELL 405 serum-
free medium (SAFC Biosciences), then transferred to ESF 921 methionine-free
medium (Expression Systems). Baculovirus stock was added when cells
reached a density of 1.6–1.8 3 106 cells/ml. 100 mg of DL-SeMet (Sigma)
were added per liter of cell culture 10 hr and again 36 hr after infection. At
68–72 hr after infection, the cells were removed from the medium, which con-
tained secreted tapasin-ERp57, by centrifugation. The medium was supple-
mented with 5 mM CaCl2, 1mM NiSO4, and 50 mM Tris-Cl (pH 8.0) and stirred
at room temperature for 20 min. The solution was centrifuged at 10,000 3 g,
filtered, and loaded onto Ni-NTA beads (QIAGEN) that were pre-equilibrated
with 300 mM NaCl, 20 mM imidazole, and 20 mM Tris-Cl (pH 8.0). Protein
was eluted with buffer supplemented with 200 mM imidazole. Proteins were
further purified by ion-exchange chromatography and by gel filtration, and
they were then concentrated as described for the native protein.
Crystallization and Data Collection
The tapasin-ERp57 heterodimers used for crystallization contain ERp57
missing only the secretion sequence (residues 25–501) and the soluble,
lumenal domain of tapasin (residues 1–392). The complex was crystallized at
22C by the hanging-drop method. The reservoir solution contained 100 mM
HEPES (pH 7.5), 20% PEG 3K, and 200 mM CaCl2. Initial small, needle-like30 Immunity 30, 21–32, January 16, 2009 ª2009 Elsevier Inc.crystals were streak-seeded into freshly set-up drops that also contained
100 mM guanidine hydrochloride. Small, rod-like crystals obtained by micro-
seeding were then used for macroseeding, eventually yielding single crystals
that measured 0.1 3 0.3 3 0.8 mm. Crystals were transferred to solutions
containing increasing concentrations of glycerol (finally 20% [v/v] glycerol),
loop mounted, and flash frozen in liquid nitrogen.
Most crystals of the native protein belonged to space group P212121 (a =
72.57, b = 74.80, c = 202.45 A˚) and typically diffracted to 3.3–3.5 A˚ resolution.
One of several hundred crystals screened belonged to space group P21 (a =
74.10, b = 72.30, c = 200.19 A˚, b = 94.61) and diffracted to 2.6 A˚. Data
were collected at 24-ID-C at the Advanced Photon Source (APS), Argonne
National Laboratory. The SeMet-substituted protein was crystallized under
the same conditions as for native protein, and all crystals belonged to the
same P212121 space group. Harvest and cryoprotection protocols were as
for the native crystals, except that 0.1% (v/v) of H2O2 was added to the cryo-
protection solution 1 min before the crystals were flash frozen. The addition of
H2O2 converts all seleniums to their oxidized state (Sharff et al., 2000), which
results in a larger anomalous signal. Crystals treated this way diffracted to
3.3 A˚ resolution. A complete anomalous data set was collected at the selenium
edge, at 24-ID-E at the APS. All data were integrated and scaled with HKL2000
(Otwinowski and Minor, 1997).
Structure Determination
The structure was initially solved at 3.3 A˚ resolution with data collected from
SeMet-substituted crystals. These crystals have one tapasin-ERp57 complex
per asymmetric unit. All 13 selenium sites were located with SHELXD
(Schneider and Sheldrick, 2002). The positions were refined and phases
were calculated with SHARP (de La Fortelle and Bricogne, 1997). The phasing
power and figure of merit were 0.92 and 0.59, respectively.We first built ERp57
by using available structures of domains a and a0 of PDI (PDB ID 2B5E) and
domains bb0 of ERp57 (PDB ID 2H8L) as guides. The partial model was used
for phase combination in SHARP, and the improved electron-density maps
were used for modeling tapasin (Figures S3A and S3B). COOT (Emsley and
Cowtan, 2004) was used for model building. Cycles of manual rebuilding,
torsion-angle dynamics, and individual B factor refinement in CNS (Brunger
et al., 1998) resulted in Rwork/Rfree values of 26.8% and 33.9%. The final model
contains residues 25–493 of ERp57, excluding the C terminus (residues
494–501), and residues 1–11, 18–27, 34–172, and 177–381 of tapasin.
Models of ERp57 and tapasin from the 3.3 A˚ resolution structure were used
in molecular replacement with the 2.6 A˚ data set collected from a native
crystal. This crystal has two tapasin-ERp57 complexes in the asymmetric
unit. We used Phaser (McCoy et al., 2007) to locate the first copy of both
ERp57 and tapasin. We built the second copy of each protein by locating
domains individually: the N- and C-terminal domains of tapasin and domains
a, b, b0, and a0 of ERp57. Rigid-body refinement was used for optimizing the
position of each of the domains in both copies of the tapasin-ERp57 complex.
After a round of torsion-angle dynamics at 5000 K (Brunger et al., 1998), a
Fo-Fc difference map was calculated, and missing residues were built into
the difference density. Composite omit maps (Figures S3C and S3D) were
calculated and used for further improving the model. Cycles of manual
rebuilding, torsion-angle dynamics, and individual B factor refinement and
the final addition of water molecules resulted in Rwork/Rfree values of 24.5%/
28.1%. NCS restraints between equivalent domains in the two copies of tapa-
sin-ERp57 were used in all stages of refinement, except for B factors. All
refinement statistics are included in Table 1.
The programs Molscript (Carson, 1997), Pymol (DeLano, 2002), and Grasp
(Nicholls et al., 1991) were used for making the figures.
Characterization of Tapasin Mutants
These assays are described in detail in the Supplemental Experimental Proce-
dures. In brief, for in vitro assays, mutants of soluble tapasin were coexpressed
with C60A ERp57 in Sf21 insect cells, and recombinant proteins were isolated
with beads coupled to the tapasin-specific mAb PaSta1 (Dick et al., 2002).
In vitro assays for MHC class I binding and peptide loading were performed
with .220.B*0801 cell extracts essentially as described (Wearsch andCresswell,
2007), except that the tapasin-ERp57 complexes were immobilized by the
PaSta1 mAb, which had minimal effects on tapasin function. The experiments
shown in Figures 4E and 4F used the PaSta2 mAb, which was produced in
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nant, soluble human tapasin expressed in insect cells (Dick et al., 2002).
For analysis in mammalian cells, wild-type and mutant tapasin were cloned
into the pBMN-IRES-EGFP retroviral expression vector and transduced
as described (Peaper and Cresswell, 2008) into 721.220 cells expressing
HLA-B*4402 (Peh et al., 1998). Transduced cells were stained with mouse
anti-HLA-A,B,C (Becton Dickinson) for evaluation of MHC class I surface
expression by FACS. For the analysis of PLCcomposition, immunoprecipitation
of tapasin and immunoblotting for associated TAP and MHC class I HC were
performed as described (Peaper and Cresswell, 2008).
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